These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32985411)

  • 41. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
    Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.
    Xhepa E; Byrne RA; Rivero F; Rroku A; Cuesta J; Ndrepepa G; Kufner S; Valiente TB; Cassese S; Garcia-Guimaraes M; Lahmann AL; Rai H; Schunkert H; Joner M; Pérez-Vizcayno MJ; Gonzalo N; Alfonso F; Kastrati A
    Clin Res Cardiol; 2019 Sep; 108(9):1059-1068. PubMed ID: 30783752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
    Wang X; Zhang M; Cheng J; Zhou H
    BMC Cardiovasc Disord; 2022 Aug; 22(1):355. PubMed ID: 35927634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges.
    Sakamoto A; Sato Y; Kawakami R; Cornelissen A; Mori M; Kawai K; Fernandez R; Fuller D; Gadhoke N; Guo L; Romero ME; Kolodgie FD; Virmani R; Finn AV
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):801-816. PubMed ID: 33470872
    [No Abstract]   [Full Text] [Related]  

  • 47. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
    Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
    Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of neointimal tissue characterization and heterogeneity of bare-metal stents and drug-eluting stents on the time course after stent implantation evaluated by integrated backscatter intravascular ultrasound.
    Yoshizane T; Tanaka S; Abe S; Ueno T; Goto Y; Kojima T; Iwama M; Arai M; Noda T; Kawasaki M
    Heart Vessels; 2019 Oct; 34(10):1639-1649. PubMed ID: 30997558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
    Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
    Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis.
    Gonzalo N; Salazar CH; Pérez-Vizcayno MJ; Gómez-Polo JC; Jiménez-Quevedo P; Jiménez-Valero S; Masotti M; Romaguera R; Fernández-Ortiz A; Escaned J; Alfonso F; Macaya C
    Rev Esp Cardiol (Engl Ed); 2021 May; 74(5):427-435. PubMed ID: 32439297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation.
    Shimono H; Kajiya T; Takaoka J; Miyamura A; Inoue T; Kitazono K; Ninomiya T; Atsuchi Y; Atsuchi N; Ohishi M
    Coron Artery Dis; 2021 Jan; 32(1):36-41. PubMed ID: 32826448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.
    Habara M; Terashima M; Nasu K; Kaneda H; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Suzuki T
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):276-84. PubMed ID: 22945378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcified neoatherosclerosis causing in-stent restenosis: prevalence, predictors, and implications.
    Garcia-Guimaraes M; Antuña P; Maruri-Sanchez R; Vera A; Cuesta J; Bastante T; Rivero F; Alfonso F
    Coron Artery Dis; 2019 Jan; 30(1):1-8. PubMed ID: 30379646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-Stent Restenosis Caused by a Calcified Nodule: A Novel Pattern of Neoatherosclerosis.
    Alfonso F; Cuesta J; Bastante T; Aguilera MC; Benedicto A; Rivero F
    Can J Cardiol; 2016 Jun; 32(6):830.e1-3. PubMed ID: 26774232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
    Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences between first-generation and second-generation drug-eluting stent regarding in-stent neoatherosclerosis characteristics: an optical coherence tomography analysis.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Obokata M; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1521-1528. PubMed ID: 29785558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.